| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 50.97B | 51.05B | 50.24B | 47.43B | 45.32B | 42.59B |
| Gross Profit | 13.06B | 13.55B | 12.57B | 10.60B | 11.16B | 11.46B |
| EBITDA | 2.56B | 3.16B | 2.85B | 1.17B | 1.64B | 1.77B |
| Net Income | 1.02B | 1.55B | 1.51B | 267.97M | 635.03M | 600.32M |
Balance Sheet | ||||||
| Total Assets | 26.63B | 26.90B | 27.64B | 25.10B | 24.44B | 23.75B |
| Cash, Cash Equivalents and Short-Term Investments | 2.30B | 2.28B | 2.18B | 2.11B | 1.83B | 1.84B |
| Total Debt | 3.73B | 3.38B | 5.57B | 5.63B | 5.56B | 5.29B |
| Total Liabilities | 9.61B | 9.51B | 11.80B | 10.95B | 10.57B | 10.52B |
| Stockholders Equity | 17.01B | 17.39B | 15.84B | 14.16B | 13.87B | 13.23B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 2.62B | 541.83M | 513.91M | 106.92M | 1.66B |
| Operating Cash Flow | 0.00 | 3.57B | 1.47B | 1.04B | 491.36M | 2.04B |
| Investing Cash Flow | 0.00 | -907.65M | -1.23B | -642.82M | -520.85M | -312.66M |
| Financing Cash Flow | 0.00 | -2.55B | -215.43M | -148.48M | -44.71M | -1.74B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
72 Outperform | ¥11.17B | 5.84 | ― | 2.39% | -0.37% | -54.58% | |
68 Neutral | ¥20.11B | 10.62 | ― | 1.74% | 7.66% | 2.64% | |
68 Neutral | ¥4.31B | 6.34 | ― | 1.55% | -1.00% | 31.15% | |
66 Neutral | ¥6.28B | 12.62 | ― | 1.22% | 1.52% | 28.70% | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
59 Neutral | ¥14.01B | 4.68 | ― | 1.61% | 0.48% | -34.95% | |
49 Neutral | ¥10.30B | -8,155.86 | ― | 0.84% | 4.28% | ― |